MARKET

ONCO

ONCO

Onconetix
NASDAQ
0.6374
-0.1190
-15.73%
After Hours: 0.6401 +0.0027 +0.42% 19:35 09/14 EDT
OPEN
0.7639
PREV CLOSE
0.7564
HIGH
0.7780
LOW
0.6374
VOLUME
553.64K
TURNOVER
--
52 WEEK HIGH
209.50
52 WEEK LOW
0.5868
MARKET CAP
2.79M
P/E (TTM)
-0.0032
1D
5D
1M
3M
1Y
5Y
1D
Onconetix Secures Bridge Financing for Realbotix Acquisition
TipRanks · 17h ago
Realbotix announces bridge loan from Onconetix
TipRanks · 20h ago
Weekly Report: what happened at ONCO last week (0907-0911)?
Weekly Report · 22h ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 6d ago
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
Benzinga · 6d ago
Weekly Report: what happened at ONCO last week (0831-0904)?
Weekly Report · 09/07 10:05
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 09/04 21:06
More
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.

Webull offers Onconetix Inc stock information, including NASDAQ: ONCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONCO stock methods without spending real money on the virtual paper trading platform.